Default company panoramic image
F89671d1 1470 4ce8 a4db e3ab0ad2ce81

Dispersol Technologies, Inc.

DisperSol uses its pharmaceutical processing technology and equipment to develop drug compositions that otherwise can not be processed

  • Stage Not Set
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD
  • Website

Company Summary

Dispersol is a high growth coompany with a development program to reformulate and manufacture challenging existing drugs. DisperSol is in advanced development of a tamper resistant /abuse deterrent platform for the manufacture of opioid drugs, that are in testing for 7 global pharma companies. The Company also is developing an oncology drug. Company has 3 issued patents and 3 patent applications. Currently expanding 3X capacity by Q4 2014 .


  • Default avatar
    Dr Gershon Yaniv

    Former CEO of IntegriCo Composites, experienced entrepreneur with 25 years leading high tech companies. Former Professor Materials at Northwestern.

  • Default avatar
    Dave Miller, PhD
    VP R&D

    Dave is the former principal scientist in charge of reformulations and manufacturing for Hoffman, la Roche.